Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Upload Avatar (500 x 500)
Jianping Weng
ioemdoffice@ustc.edu.cn
Chinese, English
Anhui

Academic Information

University of Science and Technology of China
Mayo Clinic College of Medicine
  • 1980-1985: Bachelor of Medicine, Southeast University Medical School
  • 1988-1991: Master of Clinical Medicine, Sun Yat-sen University
  • 1993-1996: Doctor of Clinical Medicine, Sun Yat-sen University
  • 1985-08 to 1988-08: Resident Physician, Nanjing 734 Factory Hospital, Ministry of Electronics Industry
  • 1991-08 to 1993-08: Physician and Chief Resident, First Affiliated Hospital of Sun Yat-sen University
  • 1996-08 to 1997-10: Attending Physician, Endocrinology Department, First Affiliated Hospital of Sun Yat-sen University
  • 1997-12 to 2000-03: Postdoctoral Researcher, Malmo General Hospital, Lund University, Sweden
  • 1997-05 to 2007-11: Various roles including Deputy Director, Director, Chief Expert, and Discipline Leader, Endocrinology Department, First Affiliated Hospital of Sun Yat-sen University
  • 2007-11 to 2011-12: Vice President, Third Affiliated Hospital of Sun Yat-sen University, responsible for research, postgraduate education, and discipline construction
  • 2011-12 to 2015-12: Vice President, Third Affiliated Hospital of Sun Yat-sen University, responsible for undergraduate teaching, continuing education, and equipment
  • 2015-12 to 2018-09: Director, Guangdong Diabetes Prevention and Treatment Key Laboratory, Chief Expert and Discipline Leader, Endocrinology and Metabolic Diseases, Third Hospital of Sun Yat-sen University
  • 2018-10 to present: Vice Minister, Life Sciences and Medicine Department, University of Science and Technology of China
  • 2020-11 to present: President, Bengbu Medical College
  • Chinese Medical Science and Technology Award (2022): Second Prize, Rank 1
  • National Science and Technology Progress Award (2011): Second Prize, Rank 1
  • Ministry of Education Science and Technology Progress Award (2006): First Prize, Rank 1
  • Beijing Science and Technology Progress Award (2012): First Prize, Rank 4
  • Chinese Medical Science and Technology Award (2012): Second Prize, Rank 4
  • Guangdong Science and Technology Progress Award (2006): First Prize, Rank 4

Research

Precision diagnosis and treatment of diabetes
Clinical and basic research on pan-vascular lesions
Clinical and basic research on metabolic liver disease
Big data and smart healthcare
  • Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study, Zheng X, Yang D, Luo S, Yan J, Guo X, Yang H, Bao W, Groop L, Dornhorst A, Weng J*, 2021
  • The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction, Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J*, 2021
  • HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes, Jiang Z, Ren W, Liang H, Yan J, Yang D, Luo S, Zheng X, Lin GW, Xian Y, Xu W, Yao B, Noble JA, Bei JX, Groop L, Weng J*, 2021
  • Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study, Zheng XY, Luo SH, Sun Y, Han MF, Liu J, Sun LY, Zhang LM, Ling P, Ding Y, Jin TC, Liu ZR, Weng JP*, 2020
  • Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease, Yan J, Yao B, Kuang H, Yang X, Huang Q, Hong T, Li Y, Dou J, Yang W, Qin G, Yuan H, Xiao X, Luo S, Shan Z, Deng H, Tan Y, Xu F, Xu W, Zeng L, Kang Z, Weng J*, 2019
  • Incidence of type 1 diabetes in China, 2010-13: population based study, Weng J*, Zhou Z, Guo L, Zhu D, Ji L, Luo X, Mu Y, Jia W; T1D China Study Group, 2018
  • Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial, Weng J*, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H, 2008
Keywords
Diabetes Precision Medicine Diagnosis Treatment Pan-Vascular Lesions Metabolic Liver Disease Big Data Smart Healthcare
Related Professors
Sihui Luo - University of Science and Technology of China
Area of Focus
Diabetes | Big Data | Real-World Research | Artificial Intelligence | Treatment | Glucose Metabolism | Pregnancy | Management | Technology | Innovation
Xueying Zheng - University of Science and Technology of China
Area of Focus
Diabetes | Multi-Omics | Precision Medicine | Gestational Diabetes | Glucose Metabolism | Chronic Diseases | Molecular Epidemiology | Type 1 Diabetes | Research | Management Strategies
Junbo Ge - University of Science and Technology of China
Area of Focus
Cardiovascular | Coronary | Diagnosis | Treatment | Innovation | Ultrasound | Stents | Intervention | Cell Therapy | Research
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.